Back to search results

Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Sarcoma · Solid Tumor, Adult · Solid Tumor, Childhood

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Johns Hopkins All Children's Hospital, St. Petersburg, Florida, United States

  • Johns Hopkins Hospital, Baltimore, Maryland, United States

    Contact: Study coordinator (Nicolas Llosa, MD) · nllosa1@jhmi.edu · 410-502-4997
    Contact: Study coordinator (Megan Petrycki, RN) · mpetryc1@jhmi.edu · 410-955-0432
    Contact: Principal Investigator (Nicolas Llosa, MD)

  • Albert Einstein College of Medicine, Children's Hospital at Montefiore, The Bronx, New York, United States

    Contact: Study coordinator (David Loeb, MD) · david.loeb@einstein.yu.edu · 718-839-7497
    Contact: Principal Investigator (David Loeb, MD)

  • New York Medical Center/ Maria Fareri Children's Hospital, Valhalla, New York, United States

    Contact: Study coordinator (Aliza Gardenswartz, MD) · Aliza.Gardenswartz@wmchealth.org · 914-594-2130
    Contact: Principal Investigator (Aliza Gardenswartz, MD)
    Mitchell Cario, MD (Sub-investigator)
Study leads

  • Nicolas Llosa, MD

    Principal Investigator

    Johns Hopkins University

View source on ClinicalTrials.gov(opens in a new tab)